NHLBI SBIR Phase IIB Bridge Awards
Supports small businesses advancing NHLBI discoveries toward regulatory clearance milestones.
The NHLBI SBIR Phase IIB Bridge Awards program provides late-stage, non-dilutive R&D funding to US small businesses seeking to advance heart, lung, blood, and sleep disorder technologies toward regulatory clearance and commercialization. The governing FOA is RFA-HL-26-014, a reissue of RFA-HL-23-009, which was released November 18, 2024. The FOA was marked expired per NOT-OD-26-006 with an updated…
Late-stage development of heart, lung, blood, and sleep disorder technologies toward regulatory clearance; limited to small businesses continuing prior NHLBI-funded SBIR or STTR Phase II work.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline